The Ambiotis news

Involvement in ImmunAID a large scale research project focused on rare auto–inflammatory disorders

Ambiotis is involved in a project funded by the European Union’s Horizon 2020 research and Innovation programme under grant agreement N°779295.

This project aims at optimizing the diagnostic, classification and clinical management of patients with auto–inflammatory disorders (AID). A wide spectrum of innovative techniques (multiomics, bioinformatic and mathematical modelling …) will be used to characterize potential pathogenic pathways at different steps of the inflammatory process and identify biomarkers in patient samples. Ambiotis will be in charge of assessing resolution markers by metabololipidomics.

More information 

Where to meet with Ambiotis between November 2018 and March 2019

Ambiotis will attend the following events :

SPIM 2018 - November 15-16, 2018 – Vichy, France

HI Europe & NI - November 27-29, 2018 - Frankfurt, Germany

Journées Jean-Paul Marty - December 4-5, 2018 – Paris, France

Cosmetagora - January 15-16, 2019 - Paris, France

Bio Europe Spring - March 25-27, 2019 - Vienna, Austria

Keystone Symposium : Lipidomics and Functional Metabolic Pathways in Disease - March 31-April 4, 2019 - Colorado, United States

Book a meeting 

New analytical services for the measurement of skin lipids

Ambiotis has recently developed new analytical services to quantify skin lipids like wax esters, squalene (neutral and peroxidized), sebaleic acid, sapienic acid,  ceramides, sterols …

Using extraction (LLE, SPE), separation (GC, LC) and detection (MS/MS, FID) technologies, our analyses can support objectivation or efficacy studies related to skin conditions with disrupted barrier, oily skin, acne …

More information